Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence
Clinical trial NCT04797000 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04797000
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-25
- Primary completion
- 2025-04-26
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.